British pharmaceutical giant GlaxoSmithKline plc (GSK) got some welcome news from the FDA late Wednesday night, as the federal regulator approved a lupus treatment drug that GSK has been pegged to market. The drug, called Benlysta, was developed by U.S.-based Human Genome Sciences (HGSI) and will be marketed and sold by GSK. Benlysta is the [...]